MY116202A - Carbapenem antibiotic, composition and method of preparation - Google Patents

Carbapenem antibiotic, composition and method of preparation

Info

Publication number
MY116202A
MY116202A MYPI97002165A MYPI19972165A MY116202A MY 116202 A MY116202 A MY 116202A MY PI97002165 A MYPI97002165 A MY PI97002165A MY PI19972165 A MYPI19972165 A MY PI19972165A MY 116202 A MY116202 A MY 116202A
Authority
MY
Malaysia
Prior art keywords
composition
preparation
carbapenem antibiotic
thereoft
prodrug
Prior art date
Application number
MYPI97002165A
Inventor
A Zimmerman Jeffrey
M Williams John
J Kaufman Michael
R Sidler Daniel
C Dubost David
A Hunke William
M Dimichele Lisa
A Berquist Paul
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795438&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY116202(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of MY116202A publication Critical patent/MY116202A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

A PHANNACEUTICAL COMPOSITION IS DISCLOSED WHICH CONTAINS A COMPOUND OF FORMULA I: OR A PHARMACEUTICALLY ACCEPTABLE SALT, PRODRUG OR HYDRATE THEREOFT IN THE STABILIZED FORM AND/OR IN COMBINATION WITH A CARBON DIOXIDE SOURCE.
MYPI97002165A 1996-05-28 1997-05-19 Carbapenem antibiotic, composition and method of preparation MY116202A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1851896P 1996-05-28 1996-05-28
GBGB9612668.5A GB9612668D0 (en) 1996-06-18 1996-06-18 Carbapenem antibiotic composition and method of preparation

Publications (1)

Publication Number Publication Date
MY116202A true MY116202A (en) 2003-11-28

Family

ID=10795438

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI97002165A MY116202A (en) 1996-05-28 1997-05-19 Carbapenem antibiotic, composition and method of preparation

Country Status (4)

Country Link
AR (1) AR006284A1 (en)
BR (1) BR9702231B8 (en)
GB (1) GB9612668D0 (en)
MY (1) MY116202A (en)

Also Published As

Publication number Publication date
BR9702231A (en) 1999-02-23
GB9612668D0 (en) 1996-08-21
BR9702231B1 (en) 2019-03-12
AR006284A1 (en) 1999-08-25
BR9702231B8 (en) 2022-01-18

Similar Documents

Publication Publication Date Title
HRP970281B1 (en) Carbapenem antibiotic, composition and method of preparation
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
AU3215597A (en) Method of inhibiting fibrosis with a somatostatin agonist
AU6645998A (en) Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
AU6114699A (en) Naphthrydine compounds and their azaisosteric analogues as antibacterials
NZ333385A (en) Solid oral dosage forms containing 35% of valsartan
AU2002211216A1 (en) Substituted aminopropoxyaryl derivatives useful as agonists for lxr
YU41199A (en) Quinoxalinediones
MX9804046A (en) 6-0-methyl erythromycin d and process for making.
AU8156394A (en) Methods for inhibiting LDL oxidation and atheroclerosis
ZA974573B (en) Carbapenem antibiotic, composition and method of preparation.
AU5727899A (en) Diaminocyclobutene-3,4-dione derivatives, their preparation and use
WO1998027930A3 (en) New use of aminopiperazine derivatives
AU4556196A (en) Azepinone compounds useful in the inhibition of ACE and NEP
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
GB2333294A (en) Cytokine production inhibitors
EP0937718A4 (en) Antibiotic tkr2648 and process for producing the same
AR006284A1 (en) A PHARMACEUTICAL COMPOSITION OF CARBAPENEM, A STABILIZED FORM OF THE SAME, PHARMACEUTICAL COMPOSITIONS OF THIS COMPOUND AND A METHOD TO STABILIZE A CARBAPENEM
AU5932394A (en) New compound, leustroducsin H, its preparation and its therapeutic use